These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 6522512)

  • 1. [Neuroleptic-induced dopaminergic supersensitivity following intermittent and continuous haloperidol administrations in rats].
    Sato M; Kashihara K; Harada T
    Seishin Shinkeigaku Zasshi; 1984; 86(10):841-4. PubMed ID: 6522512
    [No Abstract]   [Full Text] [Related]  

  • 2. Factors contributing to the up regulation of dopaminergic receptors by chronic haloperidol.
    Schweitzer JW; Schwartz R; Friedhoff AJ
    Res Commun Chem Pathol Pharmacol; 1982 Oct; 38(1):21-30. PubMed ID: 7146618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antagonism of dopamine supersensitivity by estrogen: neurochemical studies in an animal model of tardive dyskinesia.
    Gordon JH; Diamond BI
    Biol Psychiatry; 1981 Apr; 16(4):365-71. PubMed ID: 7194695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Basic and clinical studies of neuroleptic-induced supersensitivity psychosis and dyskinesia.
    Diamond BI; Borison RL
    Psychopharmacol Bull; 1986; 22(3):900-5. PubMed ID: 2879312
    [No Abstract]   [Full Text] [Related]  

  • 5. Lack of a strong influence of neuroleptic decanoates on dopaminergic and GABAergic functions.
    Ossowska K; Wolfarth S
    Pol J Pharmacol; 1995; 47(2):99-107. PubMed ID: 8688897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tardive dyskinesia: a role for the endogenous opioid system.
    Sandyk R
    Med Hypotheses; 1986 Jan; 19(1):71-4. PubMed ID: 2871480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine agonists reverse the elevated 3H-neuroleptic binding in neuroleptic-pretreated rats.
    List SJ; Seeman P
    Life Sci; 1979 Apr; 24(16):1447-52. PubMed ID: 470544
    [No Abstract]   [Full Text] [Related]  

  • 8. Spontaneous orofacial dyskinesia and dopaminergic function in rats after 6 months of neuroleptic treatment.
    Waddington JL; Cross AJ; Gamble SJ; Bourne RC
    Science; 1983 Apr; 220(4596):530-2. PubMed ID: 6132447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Continuous suppression of methamphetamine-induced supersensitivity by chronic haloperidol administration].
    Kashihara K; Fujiwara Y; Sato M
    Seishin Shinkeigaku Zasshi; 1984; 86(11):928-32. PubMed ID: 6543469
    [No Abstract]   [Full Text] [Related]  

  • 10. Lithium does not interact with haloperidol in the dopaminergic pathways of the rat brain.
    Reches A; Jackson-Lewis V; Fahn S
    Psychopharmacology (Berl); 1984; 82(4):330-4. PubMed ID: 6427824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tardive dyskinesia: a biological appraoch.
    Barbaccia ML; Trabucchi M
    Prog Clin Biol Res; 1980; 39():181-93. PubMed ID: 6105670
    [No Abstract]   [Full Text] [Related]  

  • 12. Disrupted latent inhibition in the rat with chronic amphetamine or haloperidol-induced supersensitivity: relationship to schizophrenic attention disorder.
    Solomon PR; Crider A; Winkelman JW; Turi A; Kamer RM; Kaplan LJ
    Biol Psychiatry; 1981 Jun; 16(6):519-37. PubMed ID: 7196265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Presynaptic dopamine receptors in striatal nerve endings: absence of haloperidol-induced supersensitivity.
    Raiteri M; Cerrito F; Casazza G; Levi G
    Adv Biochem Psychopharmacol; 1980; 24():37-43. PubMed ID: 7405669
    [No Abstract]   [Full Text] [Related]  

  • 14. Oral tardive dyskinesia in the rat.
    Sundén-Kuronen B; Pohto P; Alanen E
    Acta Odontol Scand; 1983 Dec; 41(6):343-8. PubMed ID: 6581673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ECT and tardive dyskinesia.
    Lerer B
    J Clin Psychiatry; 1984 Apr; 45(4):188. PubMed ID: 6715296
    [No Abstract]   [Full Text] [Related]  

  • 16. [Supersensitivity of isolated rat vas deferens to dopamine in animals pretreated wit reserpine and haloperidol (author's transl)].
    Alloza JL; Salva JA
    Arch Farmacol Toxicol; 1980 Aug; 6(2):119-30. PubMed ID: 7469495
    [No Abstract]   [Full Text] [Related]  

  • 17. Electron spin resonance spectroscopy reveals alpha-phenyl-N-tert-butylnitrone spin-traps free radicals in rat striatum and prevents haloperidol-induced vacuous chewing movements in the rat model of human tardive dyskinesia.
    Rogoza RM; Fairfax DF; Henry P; N-Marandi S; Khan RF; Gupta SK; Mishra RK
    Synapse; 2004 Dec; 54(3):156-63. PubMed ID: 15452862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic haloperidol does not increase specific dopamine receptor binding in rat frontal cortex.
    Meller E; Bohmaker K; Rosengarten H; Friedhoff AJ
    Res Commun Chem Pathol Pharmacol; 1982 Sep; 37(3):323-32. PubMed ID: 7178646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential liabilities of haloperidol and thioridazine for inducing apomorphine hypersensitivity.
    De Veaugh-Geiss J; Devanand DP; Carey RJ
    Biol Psychiatry; 1982 Nov; 17(11):1289-301. PubMed ID: 6891268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in the pattern of brain-derived neurotrophic factor immunoreactivity in the rat brain after acute and subchronic haloperidol treatment.
    Dawson NM; Hamid EH; Egan MF; Meredith GE
    Synapse; 2001 Jan; 39(1):70-81. PubMed ID: 11071712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.